Some preclinical work explores FOXO4-p53-targeting peptides against senescent cancer cells, and the developer has discussed cancer as a research interest, but there is no human evidence that FOXO4-DRI treats cancer
Risks and Benefits: Discomfort is minimal due to injections of local anaesthetic, but there is often some swelling and mild bruising in the treated area for a week or so
How CagriSema Compares With Current GLP-1 Medications One of the biggest questions people have is how CagriSema compares with medications such as Wegovy, Zepbound, or Mounjaro
US23OZM00009 2023
Most side effects are mild and temporary (nausea, constipation), and cardiovascular benefits accumulate over time
It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine